{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:36:44Z","timestamp":1791193004609,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2010,7,27]],"date-time":"2010-07-27T00:00:00Z","timestamp":1280188800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Intervent Radiol"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1007\/s00270-010-9937-4","type":"journal-article","created":{"date-parts":[[2010,7,26]],"date-time":"2010-07-26T15:13:33Z","timestamp":1280157213000},"page":"960-966","source":"Crossref","is-referenced-by-count":64,"title":["Toxicity of Irinotecan-Eluting Beads in the Treatment of Hepatic Malignancies: Results of a Multi-Institutional Registry"],"prefix":"10.1007","volume":"33","author":[{"given":"R. C. G.","family":"Martin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Howard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Tomalty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Robbins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Padr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. M.","family":"Bosnjakovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cliff","family":"Tatum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,7,27]]},"reference":[{"key":"9937_CR1","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s10434-999-0651-x","volume":"6","author":"CR Scoggins","year":"1999","unstructured":"Scoggins CR, Meszoely IM, Blanke CD et al (1999) Nonoperative management of primary colorectal cancer in patients with stage IV disease. Ann Surg Oncol 6:651\u2013657","journal-title":"Ann Surg Oncol"},{"key":"9937_CR2","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1477-7819-7-80","volume":"7","author":"RC Martin","year":"2009","unstructured":"Martin RC, Robbins K, Tomalty D et al (2009) Transarterial chemoembolisation (TACE) using irinotecan-loaded beads for the treatment of unresectable metastases to the liver in patients with colorectal cancer: an interim report. World J Surg Oncol 7:80","journal-title":"World J Surg Oncol"},{"key":"9937_CR3","first-page":"3793","volume":"26","author":"C Aliberti","year":"2006","unstructured":"Aliberti C, Tilli M, Benea G et al (2006) Trans-arterial chemoembolization (TACE) of liver metastases from colorectal cancer using irinotecan-eluting beads: Preliminary results. Anticancer Res 26:3793\u20133795","journal-title":"Anticancer Res"},{"key":"9937_CR4","first-page":"1085","volume":"21","author":"G Fiorentini","year":"2007","unstructured":"Fiorentini G, Aliberti C, Turrisi G et al (2007) Intraarterial hepatic chemoembolization of liver metastases from colorectal cancer adopting irinotecan-eluting beads: results of a phase II clinical study. In Vivo 21:1085\u20131091","journal-title":"In Vivo"},{"key":"9937_CR5","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1016\/j.jconrel.2006.09.047","volume":"116","author":"Y Tang","year":"2006","unstructured":"Tang Y, Taylor RR, Gonzalez MV et al (2006) Evaluation of irinotecan drug-eluting beads: a new drug-device combination product for the chemoembolization of hepatic metastases. J Control Release 116:e55\u2013e56","journal-title":"J Control Release"},{"key":"9937_CR6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejps.2006.09.002","volume":"30","author":"RR Taylor","year":"2007","unstructured":"Taylor RR, Tang Y, Gonzalez MV et al (2007) Irinotecan drug eluting beads for use in chemoembolization: in vitro and in vivo evaluation of drug release properties. Eur J Pharm Sci 30:7\u201314","journal-title":"Eur J Pharm Sci"},{"key":"9937_CR7","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1093\/annonc\/mdf337","volume":"13","author":"Y Xu","year":"2002","unstructured":"Xu Y, Villalona-Calero MA (2002) Irinotecan: mechanisms of tumor resistance and novel strategies for modulating its activity. Ann Oncol 13:1841\u20131851","journal-title":"Ann Oncol"},{"key":"9937_CR8","first-page":"72","volume":"12","author":"JR Hecht","year":"1998","unstructured":"Hecht JR (1998) Gastrointestinal toxicity or irinotecan. Oncology (Williston Park) 12:72\u201378","journal-title":"Oncology (Williston Park)"},{"key":"9937_CR9","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/jnci\/85.4.271","volume":"85","author":"WJ Slichenmyer","year":"1993","unstructured":"Slichenmyer WJ, Rowinsky EK, Donehower RC et al (1993) The current status of camptothecin analogues as antitumor agents. J Natl Cancer Inst 85:271\u2013291","journal-title":"J Natl Cancer Inst"},{"key":"9937_CR10","first-page":"1431","volume":"54","author":"M Potmesil","year":"1994","unstructured":"Potmesil M (1994) Camptothecins: from bench research to hospital wards. Cancer Res 54:1431\u20131439","journal-title":"Cancer Res"},{"key":"9937_CR11","doi-asserted-by":"crossref","first-page":"14873","DOI":"10.1016\/S0021-9258(17)38654-4","volume":"260","author":"YH Hsiang","year":"1985","unstructured":"Hsiang YH, Hertzberg R, Hecht S et al (1985) Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. J Biol Chem 260:14873\u201314878","journal-title":"J Biol Chem"},{"key":"9937_CR12","first-page":"4385","volume":"49","author":"YH Hsiang","year":"1989","unstructured":"Hsiang YH, Liu LF, Wall ME et al (1989) DNA topoisomerase I-mediated DNA cleavage and cytotoxicity of camptothecin analogues. Cancer Res 49:4385\u20134389","journal-title":"Cancer Res"},{"key":"9937_CR13","first-page":"1465","volume":"49","author":"C Jaxel","year":"1989","unstructured":"Jaxel C, Kohn KW, Wani MC et al (1989) Structure-activity study of the actions of camptothecin derivatives on mammalian topoisomerase I: evidence for a specific receptor site and a relation to antitumor activity. Cancer Res 49:1465\u20131469","journal-title":"Cancer Res"},{"key":"9937_CR14","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1155\/2009\/539795","volume":"2009","author":"RC Martin","year":"2009","unstructured":"Martin RC, Joshi J, Robbins K et al (2009) Transarterial chemoembolization of metastatic colorectal carcinoma with drug-eluting beads, irinotecan (DEBIRI): multi-institutional registry. J Oncol 2009:539\u2013795","journal-title":"J Oncol"},{"key":"9937_CR15","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/01.RVI.0000195323.46152.B3","volume":"17","author":"AL Lewis","year":"2006","unstructured":"Lewis AL, Gonzalez MV, Lloyd AW et al (2006) DC bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization. J Vasc Interv Radiol 17:335\u2013342","journal-title":"J Vasc Interv Radiol"},{"key":"9937_CR16","first-page":"53","volume":"6","author":"J Kaiser","year":"2009","unstructured":"Kaiser J, Thiesen J, Kramer I (2009) Stability of irinotecan-loaded drug eluting beads (DC BeadTM) used for transarterial chemoembolisation. J Oncol Pharm Pract 6:53\u201361","journal-title":"J Oncol Pharm Pract"},{"key":"9937_CR17","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.gassur.2005.08.004","volume":"10","author":"Z Morise","year":"2006","unstructured":"Morise Z, Sugioka A, Kato R et al (2006) Transarterial chemoembolization with degradable starch microspheres, irinotecan, and mitomycin-C in patients with liver metastases. J Gastrointest Surg 10:249\u2013258","journal-title":"J Gastrointest Surg"},{"key":"9937_CR18","doi-asserted-by":"crossref","first-page":"10325","DOI":"10.1021\/bi00200a013","volume":"33","author":"Z Mi","year":"1994","unstructured":"Mi Z, Burke TG (1994) Differential interactions of camptothecin lactone and carboxylate forms with human blood components. Biochemistry 33:10325\u201310336","journal-title":"Biochemistry"},{"key":"9937_CR19","first-page":"2182","volume":"7","author":"RH Mathijssen","year":"2001","unstructured":"Mathijssen RH, van Alphen RJ, Verweij J et al (2001) Clinical pharmacokinetics and metabolism of irinotecan (CPT-11). Clin Cancer Res 7:2182\u20132194","journal-title":"Clin Cancer Res"},{"key":"9937_CR20","first-page":"5944","volume":"47","author":"T Kunimoto","year":"1987","unstructured":"Kunimoto T, Nitta K, Tanaka T et al (1987) Antitumor activity of 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxy-camptothec, in a novel water-soluble derivative of camptothecin, against murine tumors. Cancer Res 47:5944\u20135947","journal-title":"Cancer Res"},{"key":"9937_CR21","first-page":"4187","volume":"51","author":"Y Kawato","year":"1991","unstructured":"Kawato Y, Aonuma M, Hirota Y et al (1991) Intracellular roles of SN-38, a metabolite of the camptothecin derivative CPT-11, in the antitumor effect of CPT-11. Cancer Res 51:4187\u20134191","journal-title":"Cancer Res"},{"key":"9937_CR22","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/jps.2600840426","volume":"84","author":"TG Burke","year":"1995","unstructured":"Burke TG, Munshi CB, Mi Z et al (1995) The important role of albumin in determining the relative human blood stabilities of the camptothecin anticancer drugs. J Pharm Sci 84:518\u2013519","journal-title":"J Pharm Sci"}],"container-title":["CardioVascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-010-9937-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00270-010-9937-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-010-9937-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T14:24:24Z","timestamp":1635776664000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00270-010-9937-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,27]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["9937"],"URL":"https:\/\/doi.org\/10.1007\/s00270-010-9937-4","relation":{},"ISSN":["0174-1551","1432-086X"],"issn-type":[{"value":"0174-1551","type":"print"},{"value":"1432-086X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,27]]}}}